Anti-DLL4 & VEGF Reference Antibody (Navicixizumab)
Produktgrößen
100 ug
£ POA
CHB451-100UG
Über dieses Produkt
- SKU:
- CHB451
- Anwendung:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- translate.label.attr.clone:
- Navicixizumab
- Klonalität:
- Recombinant Monoclonal
- Weitere Details:
- Anti-DLL4 & VEGF Reference Antibody (Navicixizumab) (CHB451) is expressed from CHO, with a configuration of BiMab. The heavy chain type is huIgG1, and the light chain type is Kappa. It has a predicted MW of 146.17 kDa.
- Immunogen:
- DLL4 & VEGF
- Isotyp:
- IgG
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- Please refer to datasheet
- Hersteller:
- Sanyou Biopharmaceuticals
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:CHB451